Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CNCR

Range Cancer Therapeutics ETF (CNCR) Price, Holdings, & News

About Range Cancer Therapeutics ETF (NASDAQ:CNCR)

Advanced Chart

Key Stats

Today's Range
$11.63
$11.82
50-Day Range
$27.45
$32.25
52-Week Range
$7.88
$16.27
Volume
1,757 shs
Average Volume
3,657 shs
Market Capitalization
$7.28 million
Assets Under Management
$6.95 million
Dividend Yield
3.11%
Net Expense Ratio
0.79%
Aggregate Rating
N/A

ETF Overview

Range Cancer Therapeutics ETF Expenses

TypeCNCRHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.79%0.56%0.56%0.54%0.53%
Other Expenses0.00%0.47%0.56%0.52%0.56%
Total Expense0.79%0.75%0.76%0.74%0.73%
Fee Waiver0.00%-0.67%-0.66%-0.50%-0.63%
Net Expense0.79%0.60%0.63%0.63%0.60%
Receive CNCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Range Cancer Therapeutics ETF and its competitors with MarketBeat's FREE daily newsletter.

CNCR ETF News Headlines

The $100 Trillion AI Story No One Is Telling You
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
Range Oncology Therapeutics Index ETF (CNCR)
See More Headlines

CNCR ETF - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Range Cancer Therapeutics ETF investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), Adobe (ADBE), Novo Nordisk A/S (NVO) and e.l.f. Beauty (ELF).

Fund Details

Issuer
Exchange Traded Concepts
Fund Name
Range Cancer Therapeutics ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:CNCR
Inception Date
10/13/2015
Fund Manager
Denise M. Krisko
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Range Oncology Therapeutics Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
1

Fund Statistics

Assets Under Management
$6.95 million
Average Daily Volume
$2.27 thousand
Discount/Premium
0.12%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Exchange Traded Concepts, LLC
Custodian
U.S. Bank, N.A.
Distributor
Quasar Distributors, LLC
Transfer Agent
U.S. Bank, N.A.
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
6,900 shs

Miscellaneous

Beta
0.95
Creation Unit
50,000
Creation Fee
$150.00
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Top 2 CNCR Holdings

  • US DOLLARS
    Holding Weight: 99.94%
  • DEPOSITS WITH BROKER FOR SHORT POSITIONS
    Holding Weight: 0.06%

This page (NASDAQ:CNCR) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners